Newormics moves into new HQ

Newormics has expanded its base of operations into a customized, newly refurbished space in Austin, Texas. The new headquarters comprises over 2400 square-foot of laboratory, office, and meeting space and is situated in the Balcones Office Park, just north of downtown and UT Austin. Here, we lead you on a quick tour of the company’s Read more about Newormics moves into new HQ[…]

Newormics Announces Intent to Grant Utility Patent on the vivoChip® by the European Patent Office

Patent covers the vivoChip® invention that Newormics licensed for use in immobilization of C. elegans for high resolution imaging. AUSTIN, TX. August 5, 2020 – Newormics LLC, a developer of the first high-throughput, high-content screening platforms for use with in vivo small animal models, announced that the European Patent Office (EPO) intends to grant a patent covering the vivoChip® technology, Read more about Newormics Announces Intent to Grant Utility Patent on the vivoChip® by the European Patent Office[…]

Newormics awarded SBIR Phase II grant from the NIMH

Newormics is excited to announce it has been awarded a $2.25M Phase II SBIR grant from the National Institutes of Health/National Institute of Mental Health (NIMH) for the continued development of the company’s in vivo imaging and screening technologies. Newormics core focus is to facilitate the use of C. elegans as a model organism for Read more about Newormics awarded SBIR Phase II grant from the NIMH[…]